澳股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

MICROBA LIFE SCIENCES LTD

0.051

+0.0012.00%

成交量：2.11万

成交额：1,075

市值：3,657.30万

市盈率：-1.48

高：0.051

开：0.051

低：0.051

收：0.050

52周最高：0.105

52周最低：0.036

股本：7.17亿

流通股本：2.86亿

量比：0.16

换手率：0.01%

股息：- -

股息率：- -

每股收益(TTM):-0.034

每股收益(LYR):-0.034

净资产收益率：-72.87%

总资产收益率：-29.09%

市净率：1.50

市盈率(LYR):-1.48

数据加载中...

总览公司新闻资讯公告

Genetic Signatures拟议合并将以发行GSS证券方式注资，不涉及现金对价

Microba生命科学：本财务期间未派发、建议或宣告任何股息

基因标记公司：合并集团有望凭借精简成本基础与潜在加速增长受益

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/MAP.AU/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MAP.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MAP.AU\",,,,,undefined,":{"symbol":"MAP.AU","market":"AU","secType":"STK","nameCN":"MICROBA LIFE SCIENCES LTD","latestPrice":0.051,"timestamp":1791522720000,"preClose":0.05,"halted":0,"volume":21074,"delay":0,"changeRate":0.01999999999999988,"nameEN":"MICROBA LIFE SCIENCES LTD","floatShares":285729013,"shares":717117274,"eps":-0.034499,"marketStatus":"休市中","change":0.001,"latestTime":"10-09 16:12:00 AEDT","open":0.051,"high":0.051,"low":0.051,"amount":1075,"amplitude":0,"askPrice":0.051,"askSize":8926,"bidPrice":0.044,"bidSize":47223,"shortable":3,"etf":0,"ttmEps":-0.034499,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":0,"beginTime":1791759600000},"marketStatusCode":7,"adr":0,"listingDate":1648994400000,"exchange":"ASX","adjPreClose":0.05,"openAndCloseTimeList":[[1791500400000,1791522000000]],"volumeRatio":0.1550194858449161,"lotSize":0,"tradeCurrency":"AUD","auctionPricing":{"symbol":"MAP.AU","preClose":0.05,"auctionPrice":0.05,"auctionVolume":61976,"auction":3,"marketStatus":"盘后竞价","timestamp":1791436193723}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MAP.AU\",,,,,undefined,":{"symbol":"MAP.AU","floatShares":285729013,"roa":"-29.09%","roe":"-72.87%","lyrEps":-0.0345,"volumeRatio":0.1550194858449161,"shares":717117274,"dividePrice":0,"high":0.051,"amplitude":0,"preClose":0.05,"low":0.051,"week52Low":0.036,"pbRate":"1.50","psRate":"2.48","week52High":0.105,"institutionHeld":0,"latestPrice":0.051,"committee":0.68206,"eps":-0.034499,"divideRate":0,"volume":21074,"delay":0,"ttmEps":-0.034499,"open":0.051,"prevYearClose":0.076,"prevWeekClose":0.049,"prevMonthClose":0.049,"prevQuarterClose":0.049,"fiveDayClose":0.049,"twentyDayClose":0.056,"sixtyDayClose":0.044,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MAP.AU\",params:#limit:5,,,undefined,":[{"date":"2026-07-15","symbol":"MAP.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1784073600000,"name":null,"time":"","dateTimestamp":1784037600000,"actualEps":null},{"date":"2026-04-29","symbol":"MAP.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1777420800000,"name":null,"time":"","dateTimestamp":1777384800000,"actualEps":null},{"date":"2026-01-28","symbol":"MAP.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1769554800000,"name":null,"time":"","dateTimestamp":1769518800000,"actualEps":null},{"date":"2025-10-27","symbol":"MAP.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1761519600000,"name":null,"time":"","dateTimestamp":1761483600000,"actualEps":null},{"market":"AU","date":"2025-07-22","symbol":"MAP.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1753106400000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MAP.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MAP.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1114429036","title":"Genetic Signatures拟议合并将以发行GSS证券方式注资，不涉及现金对价","url":"https://stock-news.laohu8.com/highlight/detail?id=1114429036","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114429036?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 07:28","pubTimestamp":1790033293,"startTime":"0","endTime":"0","summary":"Genetic Signatures——这项拟议中的合并案，其注资途径已明确：通过发行GSS证券来实现，而非采用现金对价方式。这一安排意味着，交易双方在资金结算上将完全绕开现金流的直接转移，转而依托股权交换的结构性框架推进合并进程。总的来说，这是一次结构设计上颇为巧妙的资本运作，其实际成效将依赖于市场对GSS证券的接受度及合并后实体的协同效应。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7124","GSS.AU","MAP.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126167867","title":"Microba生命科学：本财务期间未派发、建议或宣告任何股息","url":"https://stock-news.laohu8.com/highlight/detail?id=1126167867","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126167867?lang=zh_cn&edition=fundamental","pubTime":"2026-08-31 10:37","pubTimestamp":1788143832,"startTime":"0","endTime":"0","summary":"Microba生命科学（MICROBA LIFE SCIENCES LTD）在当前的财务报告期内，既未向股东派发股息，也未建议或宣告任何形式的股息分配方案。这一消息意味着，该公司在本阶段的利润分配策略上保持谨慎姿态，未动用留存收益进行分红。对于关注股东回报的投资者而言，此举或反映出公司在资金运用上的保守取向，亦可能为未来的资本开支或运营储备留出空间。整体来看，该公司在本次财务周期内完全规避了股息的支付与宣告流程，延续了零分红的政策基调。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAP.AU","BK7124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125560310","title":"基因标记公司：合并集团有望凭借精简成本基础与潜在加速增长受益","url":"https://stock-news.laohu8.com/highlight/detail?id=1125560310","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125560310?lang=zh_cn&edition=fundamental","pubTime":"2026-08-26 07:36","pubTimestamp":1787700997,"startTime":"0","endTime":"0","summary":"基因标记公司——合并后的集团预计将从精简的成本结构中获益，并可能迎来增长加速的契机。市场分析人士指出，成本基础的收窄不仅有助于提升盈利能力，更为潜在的扩张机遇创造了有利条件。值得注意的是，合并后实体的协同效应有望在中期内逐步显现，从而推动业绩增长轨迹向上修正。简而言之，这一变革性举措预示着集团将步入一个更加精简、高效且具备增长动能的新阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSS.AU","BK7501","BK7048","BK7124","MAP.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}]}}